Felodipine, a New Calcium Antagonist, as Monotherapy in Mild or Moderate Hypertension
- 1 January 1987
- journal article
- clinical trial
- Published by Springer Nature in Drugs
- Vol. 34 (3) , 139-148
- https://doi.org/10.2165/00003495-198700343-00030
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Felodipine vs hydralazine: a controlled trial as third line therapy in hypertension. Cooperative Study Group.British Journal of Clinical Pharmacology, 1986
- Use of nifedipine as monotherapy in the management of hypertensionThe American Journal of Medicine, 1985
- Hemodynamic effects of calcium channel blockers at rest and during exercise in essential hypertensionThe American Journal of Medicine, 1985
- Acute Diuretic/Natriuretic Properties of Felodipine in ManDrugs, 1985
- Long Term Experience of Felodipine in Combination with β-Blockade and Diuretics in Refractory HypertensionDrugs, 1985
- Comparative Trial of Felodipine and Nifedipine in Refractory HypertensionDrugs, 1985
- Vascular Selectivity of FelodipineDrugs, 1985
- Effects of vasodilator treatment with felodipine on haemodynamic responses to treadmill exercise in congestive heart failure.Heart, 1984
- Acute haemodynamic and metabolic effects of felodipine in congestive heart failure.Heart, 1984
- Short-term effects of felodipine, a new dihydropyridine, in hypertension.British Journal of Clinical Pharmacology, 1984